Literature DB >> 19646851

T cells in mycobacterial infection and disease.

Andrea M Cooper1.   

Abstract

There has been an increase in our understanding of the complexity of the T cell response to mycobacterial infection recently. Improved tools have allowed the determination of the location and kinetics of naïve T cell activation in the mouse as well the variety of function of mycobacteria-specific cells in humans. There is also an increased appreciation of the balance required during mycobacterial infection between anti-bacterial activity and control of the immunopathologic response. The integration of the T cell functional data with the consequences of infection should improve rational vaccine design.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19646851      PMCID: PMC2746551          DOI: 10.1016/j.coi.2009.06.004

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  60 in total

1.  Critical negative regulation of type 1 T cell immunity and immunopathology by signaling adaptor DAP12 during intracellular infection.

Authors:  Maziar Divangahi; Tony Yang; Kapilan Kugathasan; Sarah McCormick; Shunsuke Takenaka; Gordon Gaschler; Ali Ashkar; Martin Stampfli; Jack Gauldie; Jonathan Bramson; Toshiyuki Takai; Earl Brown; Wayne M Yokoyama; Naoko Aoki; Zhou Xing
Journal:  J Immunol       Date:  2007-09-15       Impact factor: 5.422

2.  Importance of T cells, gamma interferon, and tumor necrosis factor in immune control of the rapid grower Mycobacterium abscessus in C57BL/6 mice.

Authors:  Martin Rottman; Emilie Catherinot; Patrick Hochedez; Jean-François Emile; Jean-Laurent Casanova; Jean-Louis Gaillard; Claire Soudais
Journal:  Infect Immun       Date:  2007-09-17       Impact factor: 3.441

3.  NK cells lyse T regulatory cells that expand in response to an intracellular pathogen.

Authors:  Sugata Roy; Peter F Barnes; Ankita Garg; Shiping Wu; David Cosman; Ramakrishna Vankayalapati
Journal:  J Immunol       Date:  2008-02-01       Impact factor: 5.422

4.  Characterization of the deregulated immune activation occurring at late stages of mycobacterial infection in TNF-deficient mice.

Authors:  Manuela Flórido; Rui Appelberg
Journal:  J Immunol       Date:  2007-12-01       Impact factor: 5.422

5.  Mycobacterium bovis bacillus Calmette-Guérin secreting active cathepsin S stimulates expression of mature MHC class II molecules and antigen presentation in human macrophages.

Authors:  Hafid Soualhine; Ala-Eddine Deghmane; Jim Sun; Karen Mak; Amina Talal; Yossef Av-Gay; Zakaria Hmama
Journal:  J Immunol       Date:  2007-10-15       Impact factor: 5.422

6.  Improved protection against disseminated tuberculosis by Mycobacterium bovis bacillus Calmette-Guerin secreting murine GM-CSF is associated with expansion and activation of APCs.

Authors:  Anthony A Ryan; Teresa M Wozniak; Elena Shklovskaya; Michael A O'Donnell; Barbara Fazekas de St Groth; Warwick J Britton; James A Triccas
Journal:  J Immunol       Date:  2007-12-15       Impact factor: 5.422

7.  Progression of pulmonary tuberculosis and efficiency of bacillus Calmette-Guérin vaccination are genetically controlled via a common sst1-mediated mechanism of innate immunity.

Authors:  Bo-Shiun Yan; Alexander V Pichugin; Ousman Jobe; Laura Helming; Evgeniy B Eruslanov; José A Gutiérrez-Pabello; Mauricio Rojas; Yuriy V Shebzukhov; Lester Kobzik; Igor Kramnik
Journal:  J Immunol       Date:  2007-11-15       Impact factor: 5.422

8.  Distinct, specific IL-17- and IL-22-producing CD4+ T cell subsets contribute to the human anti-mycobacterial immune response.

Authors:  Thomas J Scriba; Barbara Kalsdorf; Deborah-Ann Abrahams; Fatima Isaacs; Jessica Hofmeister; Gillian Black; Hisham Y Hassan; Robert J Wilkinson; Gerhard Walzl; Sebastian J Gelderbloem; Hassan Mahomed; Gregory D Hussey; Willem A Hanekom
Journal:  J Immunol       Date:  2008-02-01       Impact factor: 5.422

9.  Immunisation with BCG and recombinant MVA85A induces long-lasting, polyfunctional Mycobacterium tuberculosis-specific CD4+ memory T lymphocyte populations.

Authors:  Natalie E R Beveridge; David A Price; Joseph P Casazza; Ansar A Pathan; Clare R Sander; Tedi E Asher; David R Ambrozak; Melissa L Precopio; Phillip Scheinberg; Nicola C Alder; Mario Roederer; Richard A Koup; Daniel C Douek; Adrian V S Hill; Helen McShane
Journal:  Eur J Immunol       Date:  2007-11       Impact factor: 5.532

10.  Initiation of the adaptive immune response to Mycobacterium tuberculosis depends on antigen production in the local lymph node, not the lungs.

Authors:  Andrea J Wolf; Ludovic Desvignes; Beth Linas; Niaz Banaiee; Toshiki Tamura; Kiyoshi Takatsu; Joel D Ernst
Journal:  J Exp Med       Date:  2007-12-24       Impact factor: 14.307

View more
  41 in total

1.  Mycobacterium tuberculosis PE25/PPE41 protein complex induces activation and maturation of dendritic cells and drives Th2-biased immune responses.

Authors:  Wei Chen; Yige Bao; Xuerong Chen; Jeremy Burton; Xueli Gong; Dongqing Gu; Youjun Mi; Lang Bao
Journal:  Med Microbiol Immunol       Date:  2015-08-30       Impact factor: 3.402

2.  Pulmonary M. tuberculosis infection delays Th1 immunity via immunoadaptor DAP12-regulated IRAK-M and IL-10 expression in antigen-presenting cells.

Authors:  M Jeyanathan; S McCormick; R Lai; S Afkhami; C R Shaler; C N Horvath; D Damjanovic; A Zganiacz; N Barra; A Ashkar; M Jordana; N Aoki; Z Xing
Journal:  Mucosal Immunol       Date:  2013-10-30       Impact factor: 7.313

3.  CXCL5-secreting pulmonary epithelial cells drive destructive neutrophilic inflammation in tuberculosis.

Authors:  Geraldine Nouailles; Anca Dorhoi; Markus Koch; Jens Zerrahn; January Weiner; Kellen C Faé; Frida Arrey; Stefanie Kuhlmann; Silke Bandermann; Delia Loewe; Hans-Joachim Mollenkopf; Alexis Vogelzang; Catherine Meyer-Schwesinger; Hans-Willi Mittrücker; Gayle McEwen; Stefan H E Kaufmann
Journal:  J Clin Invest       Date:  2014-02-10       Impact factor: 14.808

4.  Maintenance of peripheral T cell responses during Mycobacterium tuberculosis infection.

Authors:  William W Reiley; Susan T Wittmer; Lynn M Ryan; Sheri M Eaton; Laura Haynes; Gary M Winslow; David L Woodland
Journal:  J Immunol       Date:  2012-10-01       Impact factor: 5.422

Review 5.  Th1 cytokines, true functional signatures for protective immunity against TB?

Authors:  Gucheng Zeng; Guoliang Zhang; Xinchun Chen
Journal:  Cell Mol Immunol       Date:  2017-11-20       Impact factor: 11.530

6.  Enhancement of Antituberculosis Immunity in a Humanized Model System by a Novel Virus-Vectored Respiratory Mucosal Vaccine.

Authors:  Yushi Yao; Rocky Lai; Sam Afkhami; Siamak Haddadi; Anna Zganiacz; Fatemeh Vahedi; Ali A Ashkar; Charu Kaushic; Mangalakumari Jeyanathan; Zhou Xing
Journal:  J Infect Dis       Date:  2017-07-01       Impact factor: 5.226

Review 7.  Cellular response to mycobacteria: balancing protection and pathology.

Authors:  Egídio Torrado; Richard T Robinson; Andrea M Cooper
Journal:  Trends Immunol       Date:  2011-01-06       Impact factor: 16.687

8.  Mycobacterium tuberculosis PPD-induced immune biomarkers measurable in vitro following BCG vaccination of UK adolescents by multiplex bead array and intracellular cytokine staining.

Authors:  Steven G Smith; Maeve K Lalor; Patricia Gorak-Stolinska; Rose Blitz; Natalie E R Beveridge; Andrew Worth; Helen McShane; Hazel M Dockrell
Journal:  BMC Immunol       Date:  2010-07-07       Impact factor: 3.615

Review 9.  Cytokines in the balance of protection and pathology during mycobacterial infections.

Authors:  Egídio Torrado; Andrea M Cooper
Journal:  Adv Exp Med Biol       Date:  2013       Impact factor: 2.622

10.  Age-dependent association between pulmonary tuberculosis and common TOX variants in the 8q12-13 linkage region.

Authors:  Audrey V Grant; Jamila El Baghdadi; Ayoub Sabri; Safa El Azbaoui; Kebir Alaoui-Tahiri; Ismail Abderrahmani Rhorfi; Yasser Gharbaoui; Ahmed Abid; Majid Benkirane; Vaomalala Raharimanga; Vincent Richard; Marianna Orlova; Anne Boland; Mélanie Migaud; Satoshi Okada; Daniel K Nolan; Jacinta Bustamante; Luis B Barreiro; Erwin Schurr; Stephanie Boisson-Dupuis; Voahangy Rasolofo; Jean-Laurent Casanova; Laurent Abel
Journal:  Am J Hum Genet       Date:  2013-02-14       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.